Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Accumulated Expenses (2017 - 2025)

Catheter Precision (VTAK) has disclosed Accumulated Expenses for 9 consecutive years, with $75000.0 as the latest value for Q4 2025.

  • Quarterly Accumulated Expenses fell 95.16% to $75000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $75000.0 through Dec 2025, down 95.16% year-over-year, with the annual reading at $75000.0 for FY2025, 95.16% down from the prior year.
  • Accumulated Expenses for Q4 2025 was $75000.0 at Catheter Precision, down from $1.4 million in the prior quarter.
  • The five-year high for Accumulated Expenses was $7.5 million in Q4 2022, with the low at $4000.0 in Q2 2024.
  • Average Accumulated Expenses over 5 years is $1.6 million, with a median of $1.4 million recorded in 2025.
  • Peak annual rise in Accumulated Expenses hit 11106.35% in 2024, while the deepest fall reached 99.79% in 2024.
  • Over 5 years, Accumulated Expenses stood at $2.0 million in 2021, then skyrocketed by 273.45% to $7.5 million in 2022, then tumbled by 76.84% to $1.7 million in 2023, then decreased by 10.68% to $1.5 million in 2024, then crashed by 95.16% to $75000.0 in 2025.
  • According to Business Quant data, Accumulated Expenses over the past three periods came in at $75000.0, $1.4 million, and $72000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.